PRKAA1 and COVID-19: These results add to overwhelming evidence implicating MMPs and AMPK in the pathogenesis of adverse cardiac remodeling in hypertension, myocardial infarction, and heart failure [59,61,110,111,112,113,114,115,116,117,118,119,120] (all of which are comorbidities in COVID-19).